These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30201375)

  • 1. Inhibition of α2C-adrenoceptors ameliorates cisplatin-induced acute renal failure in rats.
    Tsutsui H; Shimokawa T; Miura T; Takama M; Nishinaka T; Terada T; Yamagata M; Yukimura T
    Eur J Pharmacol; 2018 Nov; 838():113-119. PubMed ID: 30201375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renoprotective effect of yohimbine on ischaemia/reperfusion-induced acute kidney injury through α2C-adrenoceptors in rats.
    Shimokawa T; Tsutsui H; Miura T; Nishinaka T; Terada T; Takama M; Yoshida S; Tanba T; Tojo A; Yamagata M; Yukimura T
    Eur J Pharmacol; 2016 Jun; 781():36-44. PubMed ID: 27041645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-treatment with JP-1302 protects against renal ischemia/reperfusion-induced acute kidney injury in rats.
    Shimokawa T; Tsutsui H; Miura T; Takama M; Hayashi K; Nishinaka T; Terada T; Yoneda K; Yamagata M; Yukimura T
    J Pharmacol Sci; 2019 Mar; 139(3):137-142. PubMed ID: 30665845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats.
    Shimokawa T; Yoneda K; Yamagata M; Hayashi K; Tomita S
    Eur J Pharmacol; 2020 Mar; 871():172917. PubMed ID: 31935395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yohimbine protects against endotoxin-induced acute lung injury by blockade of alpha 2A adrenergic receptor in rats.
    Lin Y; Zhu X; Yao WZ; Yang YL; A LT; Chen L
    Chin Med J (Engl); 2011 Apr; 124(7):1069-74. PubMed ID: 21542970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-ribose ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice.
    Ueki M; Ueno M; Morishita J; Maekawa N
    Tohoku J Exp Med; 2013 Mar; 229(3):195-201. PubMed ID: 23438786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
    Fahmi AN; Shehatou GS; Shebl AM; Salem HA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):819-30. PubMed ID: 27215580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective ET(A) receptor blockade protects against cisplatin-induced acute renal failure in male rats.
    Helmy MM; Helmy MW; Abd Allah DM; Abo Zaid AM; Mohy El-Din MM
    Eur J Pharmacol; 2014 May; 730():133-9. PubMed ID: 24632086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
    Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
    Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
    Sherif IO; Al-Mutabagani LA; Alnakhli AM; Sobh MA; Mohammed HE
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1572-9. PubMed ID: 25825359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Cisplatin Nephrotoxicity by Morphine and Its Attenuation by the Opioid Antagonist Naltrexone.
    Aminian A; Javadi S; Rahimian R; Dehpour AR; Asadi Amoli F; Moghaddas P; Ejtemaei Mehr S
    Acta Med Iran; 2016 Jul; 54(7):422-9. PubMed ID: 27424012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
    Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
    Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α2C-Adrenoceptors modulate L-DOPA uptake in opossum kidney cells and in the mouse kidney.
    Moura E; Silva E; Serrão MP; Afonso J; Kozmus CE; Vieira-Coelho MA
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F928-38. PubMed ID: 22859407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant and anti-inflammatory potential of pomegranate rind extract to ameliorate cisplatin-induced acute kidney injury.
    Karwasra R; Kalra P; Gupta YK; Saini D; Kumar A; Singh S
    Food Funct; 2016 Jul; 7(7):3091-101. PubMed ID: 27273121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
    Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
    Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury.
    Ma ZN; Li YZ; Li W; Yan XT; Yang G; Zhang J; Zhao LC; Yang LM
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage.
    Sahu BD; Kuncha M; Sindhura GJ; Sistla R
    Phytomedicine; 2013 Mar; 20(5):453-60. PubMed ID: 23353054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effects of montelukast in an experimental model of cisplatin nephrotoxicity in rats.
    Gad AM; El-Raouf OMA; El-Sayeh BM; Fawzy HM; Abdallah DM
    J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28902463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-α, IL-6 and IL-10 expressions, responsible for disparity in action of curcumin against cisplatin-induced nephrotoxicity in rats.
    Kumar P; Sulakhiya K; Barua CC; Mundhe N
    Mol Cell Biochem; 2017 Jul; 431(1-2):113-122. PubMed ID: 28258441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin B2 receptor deletion and blockage ameliorates cisplatin-induced acute renal injury.
    Estrela GR; Wasinski F; Bacurau RF; Malheiros DM; Câmara NO; Araújo RC
    Int Immunopharmacol; 2014 Sep; 22(1):115-9. PubMed ID: 24975837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.